bortezomib will boost the stage or outcome of flibanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Improved flibanserin adverse results may possibly come about if coadministered with multiple weak CYP3A4 inhibitors.This medication is used to treat selected kinds of cancer (such as multiple myeloma, mantle cel